Amgen recent drugs

Discussion in 'Amgen' started by anonymous, Aug 25, 2016 at 12:05 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Brodalumab and Parsabiv - Can't get approved

    When they get approved, Amgen can't sell them (Repatha, Corlanor)

    Is this company a joke or what? The glory days are long gone.
     

  2. anonymous

    anonymous Guest

    Hey, what about Kepivance and NPlate. We sold the shit out of those!
     
  3. anonymous

    anonymous Guest

    Don't forgot Kyprolis hasn't reached $1B dollars 4 years post launch. This product was worth only a $4B acquisition cost. Amgen overspends again.
     
  4. anonymous

    anonymous Guest

    Never forget Kineret!